N-α-Boc-N-ω-,N-ω′-di-Z-L-arginine

N-α-Boc-N-ω-,N-ω′-di-Z-L-arginine is a protected L-arginine derivative in which the α-amino group is Boc-protected while both guanidinium nitrogens are protected as benzyloxycarbonyl (Z) carbamates, yielding a bis-Z, Nω,Nω′-protected guanidine motif. The molecule retains the L-configuration at the α-stereocenter and presents an ester-free amino acid scaffold with a free carboxyl group, enabling controlled peptide coupling and downstream deprotection. Benzyloxycarbonyl groups on the guanidine functionality modulate strong basicity and reduce side reactions during solid-phase or solution peptide synthesis, while the Boc group supports orthogonal deprotection strategies. The protected guanidine framework can be unmasked to regenerate the native arginine charge pattern, making this compound a chiral, protecting-group-defined intermediate for peptide construction and functional guanidinium chemistry.

1. Protected Arginine Peptide Synthesis

N-α-Boc-N-ω-,N-ω′-di-Z-L-arginine supports peptide building block preparation for research and manufacturing workflows that require orthogonally protected arginine residues. The α-Boc protection provides a predictable N-terminal activation handle for peptide coupling, while the di-Z guanidine protection suppresses guanidinium reactivity during coupling and minimizes undesired side reactions such as acylation or salt formation. The free carboxylic acid enables C-terminal activation using standard amino acid coupling chemistries, allowing incorporation into peptide chains with stereochemical retention at the α-carbon. Regenerated guanidinium after deprotection enables formation of arginine-specific salt bridges and hydrogen-bonding patterns in peptides and peptidomimetics, supporting downstream scaffold generation and applied peptide science.

2. Orthogonal Deprotection Strategy

N-α-Boc-N-ω-,N-ω′-di-Z-L-arginine is suited to orthogonal protecting-group schemes that separate α-amino unmasking from guanidine reactivation. The Boc group on the α-amino nitrogen can be removed under conditions distinct from those used to cleave benzyloxycarbonyl carbamates on the guanidine nitrogens, enabling sequential exposure of reactive functionalities. The resulting controlled unveiling of the guanidinium charge can be used to time peptide cyclization, conjugation, or post-assembly functionalization steps without premature salt formation or side reactivity. This protecting-group architecture makes the compound applicable as a chiral intermediate in protected amino acid synthesis and in process chemistry routes where selective deprotection control impacts impurity profiles and downstream purification.

3. Bioconjugation And Chemical Biology

N-α-Boc-N-ω-,N-ω′-di-Z-L-arginine can be employed in chemical biology programs that require incorporation of arginine-like cationic motifs into biomolecule conjugates. The protected guanidine functionality allows handling under coupling conditions without uncontrolled basicity, while the L-arginine backbone provides a stereochemically defined scaffold for generating cationic binding interfaces after deprotection. The free carboxyl group and protected amines facilitate conversion into activated derivatives for attaching to peptides, linkers, or functional handles used in biomolecule labeling strategies. Regenerated guanidinium can then participate in electrostatic interactions and specific binding microenvironments, enabling construction of charged analogs for studying molecular recognition, protein-peptide interfaces, and arginine-dependent chemical behavior.

4. Peptidomimetics And SAR Studies

N-α-Boc-N-ω-,N-ω′-di-Z-L-arginine serves as a chiral precursor for peptidomimetic and structure-activity relationship (SAR) studies where arginine side-chain geometry and charge presentation must be controlled. The bis-Z guanidine protection provides a stable, non-basic intermediate that can be incorporated into analogs during synthesis while preserving the stereochemical identity of the L-α-center. Sequential deprotection enables generation of the native guanidinium group, supporting the design of cationic pharmacophores, receptor-binding motifs, or cell-penetrating-like motifs in non-natural peptide analogs. The compound's protected amino acid format aligns with iterative medicinal chemistry synthesis of libraries, supporting downstream formation of analog series that differ in backbone length, linker identity, or side-chain modifications while maintaining arginine charge fidelity.

5. Pharmaceutical Intermediate Preparation

N-α-Boc-N-ω-,N-ω′-di-Z-L-arginine is applicable to pharmaceutical intermediate preparation where protected amino acid derivatives are manufactured for downstream peptide or peptidomimetic assembly. The presence of Boc and Z protecting groups enables controlled manufacturing of arginine-containing intermediates with reduced guanidinium-associated process complications such as salt formation and variable reactivity. The free carboxylic acid supports standardized conversion into coupling-ready forms, while the L-configuration provides a defined stereochemical input for consistent peptide construction. Deprotection-ready design allows conversion into arginine-bearing fragments used in drug discovery chemistry, process chemistry intermediate chains, and specialty chemical production requiring reproducible protected amino acid building blocks.

1. Cationic cell-penetrating peptides are potent furin inhibitors

2. Olfactory receptor based piezoelectric biosensors for detection of alcohols related to food safety applications

3. P-selectin and Complement’s Role in a Neonatal Model of Germinal Matrix Hemorrhage-Induced Secondary Injury

4. Sex differences in oxidative stress level and antioxidative enzymes expression and activity in obese pre-diabetic elderly rats treated with metformin or liraglutide

5. TMEM16F and dynamins control expansive plasma membrane reservoirs